Global /United States /Healthcare /Drug Manufacturers - General /SDEV

Stablecoin Development Corp.

SDEV

• NYSEAMERICAN: SDEV • Delayed

1.27USD 0.8%

As of 13 June 2026, Stablecoin Development Corp. has a market cap of $33.81M USD, ranking #33407 globally and #4709 in the United States. It ranks #3013 in the Healthcare sector, and #1033 in the Drug Manufacturers - General industry.

Global Rank

33407

Country Rank

4709

Sector Rank

3013

Industry Rank

1033

Key Stats

Market Cap

$33.81MUSD

Enterprise Value

$26.8MUSD

EBITDA (TTM)

-$7.58MUSD

Net Income (TTM)

-$22.14MUSD

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Michael Kazley open_in_new

Employees

Founded

2000

Website

stabledev.com open_in_new

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.8%	-8.6%	-15%	-87%	-80%	-95%	-57%	-99%	-100%

News

SDEV Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NYSE American (NYSEAMERICAN / AMEX) MIC: XASE PRIMARY	SDEV ISIN: US66987P5089 Shares Out.: Shares Outstanding: 27.116M¹ Shares Float: 1.209M² TV: TradingView: AMEX: SDEV SA: Stock Analysis: NYSEAMERICAN: SDEV YF: Yahoo Finance: SDEV GF: Google Finance: NYSEAMERICAN: SDEV NQ: NASDAQ: SDEV BA: Barron's: SDEV MS: Morningstar: XASE: SDEV	1.27 USD	TV: TradingView: AMEX: SDEV SA: Stock Analysis: NYSEAMERICAN: SDEV YF: Yahoo Finance: SDEV GF: Google Finance: NYSEAMERICAN: SDEV NQ: NASDAQ: SDEV BA: Barron's: SDEV MS: Morningstar: XASE: SDEV

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Stablecoin Development Corp.

Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaBay Pharmaceuticals, Inc. and changed its name to Stablecoin Development Corporation in April 2026. Stablecoin Development Corporation was incorporated in 2000 and is headquartered in Emeryville, California.

Similar Companies

Industry: Drug Manufacturers - General (United States)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Merck & Co., Inc. NYSE: MRK	$274.03B 810K%	15.1	United States
Pfizer Inc. NYSE: PFE	$149.38B 442K%	19.5	United States
Bristol-Myers Squibb Co. NYSE: BMY	$117.58B 348K%	16.8	United States

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 951K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 854K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 812K%	20.5	Switzerland
Novo Nordisk A/S CPH: NOVO-B	$181.82B 1.18T DKK 538K%	11.5	Denmark
Sanofi EPA: SAN	$110.1B 95.26B EUR 326K%	19.9	France
GSK plc LSE: GSK	$108.46B 80.96B GBP 321K%	14.6	United Kingdom

chevron_leftBack